Rtw Investments, LP Immunocore Holdings PLC Transaction History
Rtw Investments, LP
- $6.27 Billion
- Q3 2024
A detailed history of Rtw Investments, LP transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Rtw Investments, LP holds 4,869,798 shares of IMCR stock, worth $138 Million. This represents 2.42% of its overall portfolio holdings.
Number of Shares
4,869,798
Previous 4,869,798
-0.0%
Holding current value
$138 Million
Previous $165 Million
8.14%
% of portfolio
2.42%
Previous 2.76%
Shares
10 transactions
Others Institutions Holding IMCR
# of Institutions
140Shares Held
40.8MCall Options Held
197KPut Options Held
451K-
Wellington Management Group LLP Boston, MA7.05MShares$200 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.5MShares$184 Million0.12% of portfolio
-
Primecap Management CO Pasadena, CA2.47MShares$70 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.16MShares$61.1 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY1.52MShares$42.9 Million0.51% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.24B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...